SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2023 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 7th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) dated as of February 3, 2023, is between Genetic Technologies Limited, an Australian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).